Showing 1481-1490 of 1732 results for "".
Posttraumatic Headache: A Comprehensive Approach
https://practicalneurology.com/diseases-diagnoses/headache-pain/posttraumatic-headache-a-comprehensive-approach/32130/A multimodal, comprehensive, individualized approach to the treatment of posttraumatic headache is essential to optimize outcomes.Inpatient Rehabilitation Following Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/inpatient-rehabilitation-following-traumatic-brain-injury/31989/Unique care and benefits of inpatient rehabilitation facilities compared with other care settingsCOVID-19, Vaccinations & Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/covid-19-vaccinations-multiple-sclerosis/31876/Multiple sclerosis and its disease-modifying treatments affect risks of COVID-19 and response to COVID-19 vaccination.- Letters to the Editor: The tPA Debate Continues: “Dr. Anonymous” Respondshttps://practicalneurology.com/columns/practice-management/letters-to-the-editor-the-tpa-debate-continues-dr-anonymous-responds/31488/Ongoing Debate on tPA Use in Acute Stroke ManagementAn anonymous physician from Oklahoma responds to prior discussions on the use of tissue plasminogen activator (tPA) in acute stroke treatment, emphasizing a cautious approach grounded in ethical and practical considerations. The physician clarifies
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0507Dementia-pdf/31172/Progranulin Emerges as a Key Player in Frontotemporal Dementia ResearchIn the evolving landscape of neurodegenerative disease research, progranulin has rapidly ascended to prominence, akin to a breakout star in a high-stakes competition. Progranulin, a 593 amino acid glycoprotein, has been identifie
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0606Dementia-pdf/31301/Dementia in Parkinson’s Disease: Diagnostic Challenges and Emerging TreatmentsDavid S. Geldmacher, MD, highlights the complexities in diagnosing dementia associated with Parkinson’s disease (PDD) in his Practical Neurology column. Despite Parkinson’s disease (PD) primarily being recognized as a move
- Protecting Stroke Patients from Seizureshttps://practicalneurology.com/diseases-diagnoses/stroke/pn0407-post-stroke-pdf/31194/Post-Stroke Seizures: Epidemiology, Classification, and ManagementAs the global population ages, the incidence of post-stroke seizures is expected to rise, highlighting their clinical significance in neurology. Stroke markedly increases the risk of seizures, with a 23- to 35-fold higher incidence co
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN1105dementia-pdf/31374/Managing challenging behaviors in dementia patients remains a significant hurdle for both clinicians and caregivers. In his insightful commentary for Practical Neurology, Dr. David S. Geldmacher highlights the complexities associated with treating behavioral and psychiatric symptoms of dementia (BPS
- Seeing the Other Side of Parkinson's Diseasehttps://practicalneurology.com/diseases-diagnoses/movement-disorders/PN0405Parkinsons-pdf/31469/Parkinson’s disease (PD), first described by James Parkinson in 1817, has long been a challenging condition for physicians due to limited treatment options. Historically, management was primarily palliative, focusing on maintaining patient comfort as motor control and autonomic functions progressive
- Making the Switch: When and How to Step-Up MS Therapyhttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN1108MS-pdf/30974/Advancements and Considerations in Multiple Sclerosis TherapeuticsOver the past quarter-century, Multiple Sclerosis (MS) treatment has evolved rapidly, marked by the FDA approval of six disease-modifying therapies (DMTs) with several more in development. This acceleration contrasts with the decade-l